Expression profiling analyses of gonadotropin responses and tumor development in the absence of inhibins

Kathleen H Burns1, Gabe E Owens, Samuel C Ogbonna

  • 1Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, USA.

Endocrinology
|September 10, 2003
PubMed

Insights

Transgenic mouse models with disrupted pituitary-gonad signaling reveal key genes in ovarian and adrenal tissue. These findings advance our understanding of reproductive biology and associated pathologies.

Area of Science:

  • Endocrinology
  • Genomics
  • Molecular Biology

Background:

  • Transgenic mouse models with disrupted pituitary-gonad endocrine signaling offer insights into gonadotropin and inhibin function.
  • These models mimic pathological states and exhibit ovarian tissue variations, aiding cell-specific gene identification.

Purpose of the Study:

  • To comprehensively profile gene expression in the mammalian ovary and adrenal gland using FSHbeta and inhibin alpha knockout mouse models.
  • To identify and characterize novel genes involved in ovarian and adrenal physiology and pathology.

Main Methods:

  • Utilized mRNA expression profiling technologies, including Affymetrix GeneChip and NIA 15K murine cDNA microarrays.
  • Identified differentially expressed transcripts and performed Northern blot analysis for validation.
  • Conducted in situ hybridization to localize the expression of 10 specific mRNAs.

Main Results:

  • Hundreds of transcripts were found to be differentially expressed compared to wild-type mice.
  • Over 30 differentially expressed transcripts were selected for further characterization.
  • Expression patterns and potential functions of 10 localized mRNAs (e.g., Bcat1, FOXO1, 24p3) were investigated.

Conclusions:

  • The study identified numerous genes with altered expression in knockout mouse models, providing a deeper understanding of ovarian and adrenal function.
  • The characterized genes, including melanocyte-specific gene 1, SN2, Bcat1, FOXO1, 24p3, and others, are implicated in critical physiological and pathological processes.
  • These findings highlight the utility of genetically engineered mouse models in dissecting complex endocrine signaling pathways and identifying novel molecular players.

Related Concept Videos